John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
Blog
Several biotech companies have been thriving in Murrieta due to a city council decision that started with an idea to
Murrieta Genomics start-up TX Genetic Research was recently awarded second place in a national competition held by Golden Helix,
Murrieta Genomics, the
provider of genomics services and a launch pad for genomic sequencing startups,
will be hosting a lunch and learn
Press Releases
Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments
Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample
Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup
Murrieta Genomics and SimplSeq to Participate in Life Science Nation's Digital RESI Partnering Event
Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services